Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000111

Options or other derivatives

  • Chief Medical Officer acquired 25,124 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-07-01 Grant or award : show line 1 in the form Restricted stock units +25,124 25,124 D
Loading xslF345X04/wk-form4_1688673850.xml…